NasdaqGS - Nasdaq Real Time Price USD
IDEXX Laboratories, Inc. (IDXX)
At close: November 15 at 4:00 PM EST
After hours: November 15 at 4:51 PM EST
Research Analysis
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 7 | 6 | 7 | 12 |
| Avg. Estimate | 2.39 | 3.03 | 10.73 | 11.88 |
| Low Estimate | 2.35 | 2.92 | 10.42 | 11.31 |
| High Estimate | 2.43 | 3.11 | 11.04 | 12.26 |
| Year Ago EPS | 2.32 | 2.81 | 10.06 | 10.73 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 5 | 3 | 9 | 11 |
| Avg. Estimate | 934.57M | 1.02B | 3.88B | 4.16B |
| Low Estimate | 930.17M | 1.02B | 3.87B | 4.08B |
| High Estimate | 938M | 1.02B | 3.91B | 4.29B |
| Year Ago Sales | 901.6M | 964.1M | 3.66B | 3.88B |
| Sales Growth (year/est) | 3.66% | 5.58% | 6.04% | 7.20% |
Earnings History
| CURRENCY IN USD | 12/31/2023 | 3/31/2024 | 6/30/2024 | 9/30/2024 |
|---|---|---|---|---|
| EPS Est. | 2.12 | 2.68 | 2.87 | 2.69 |
| EPS Actual | 2.32 | 2.81 | 3.02 | 2.8 |
| Difference | 0.2 | 0.13 | 0.15 | 0.11 |
| Surprise % | 9.39% | 4.79% | 5.20% | 4.26% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 2.39 | 3.03 | 10.73 | 11.88 |
| 7 Days Ago | 2.38 | 3.02 | 10.78 | 11.91 |
| 30 Days Ago | 2.52 | 3.07 | 10.83 | 12.23 |
| 60 Days Ago | 2.52 | 3.08 | 10.83 | 12.22 |
| 90 Days Ago | 2.52 | 3.08 | 10.83 | 12.22 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | 1 | 3 | 1 |
| Up Last 30 Days | -- | 1 | 3 | 1 |
| Down Last 7 Days | 8 | 5 | -- | 9 |
| Down Last 30 Days | 8 | 6 | -- | 10 |
Growth Estimates
| CURRENCY IN USD | IDXX | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | 2.94% | -- | -- | 5.00% |
| Next Qtr. | 7.80% | -- | -- | 12.00% |
| Current Year | 6.66% | -- | -- | 2.10% |
| Next Year | 10.76% | -- | -- | 12.20% |
Upgrades & Downgrades
| Reiterates | Piper Sandler: Neutral to Neutral | 11/4/2024 |
| Maintains | Barclays: Overweight to Overweight | 11/4/2024 |
| Maintains | JP Morgan: Overweight to Overweight | 10/11/2024 |
| Maintains | Stifel: Hold to Hold | 10/10/2024 |
| Maintains | Piper Sandler: Neutral to Neutral | 8/14/2024 |
| Initiated | BTIG: Buy | 7/25/2024 |
Related Tickers
MTD Mettler-Toledo International Inc.
1,179.58
-4.70%
WAT Waters Corporation
358.46
-4.85%
MEDP Medpace Holdings, Inc.
310.63
-7.23%
TMO Thermo Fisher Scientific Inc.
513.08
-3.74%
DHR Danaher Corporation
230.50
-3.71%
CRL Charles River Laboratories International, Inc.
187.74
-4.65%
A Agilent Technologies, Inc.
127.07
-2.42%
IQV IQVIA Holdings Inc.
192.68
-5.06%
DGX Quest Diagnostics Incorporated
160.44
+2.30%
ILMN Illumina, Inc.
135.05
-5.05%